Leukocyte Telomere Length in Relation to Pancreatic Cancer Risk: A Prospective Study

Daniele Campa; Bjoern Mergarten; Immaculata De Vivo; Marie-Christine Boutron-Ruault; Antoine Racine; Gianluca Severi; Alexandra Nieters; Verena A Katzke; Antonia Trichopoulou; Nikos Yiannakouris; Dimitrios Trichopoulos; Heiner Boeing; J Ramon Quiros; Eric J Duell; Esther Molina-Montes; Jose Mara Huerta; Eva Ardanaz; Miren Dorronsoro; Kay-Tee Khaw; Nicholas Wareham; Ruth C Travis; Domenico Palli; Valeria Pala; Rosario Tumino; Alessio Naccarati; Salvatore Panico; Paolo Vineis; Elio Riboli; Afshan Siddiq; HB Bueno-de-Mesquita; Petra H Peeters; Peter M Nilsson; Malin Sund; Weimin Ye; Eiliv Lund; Mie Jareid; Elisabete Weiderpass; Talita Duarte-Salles; So Yeon Kong; Magdalena Stepien; Federico Canzian; Rudolf Kaaks

Journal article

Leukocyte Telomere Length in Relation to Pancreatic Cancer Risk: A Prospective Study

Daniele Campa, Bjoern Mergarten, Immaculata De Vivo, Marie-Christine Boutron-Ruault, Antoine Racine, Gianluca Severi, Alexandra Nieters, Verena A Katzke, Antonia Trichopoulou, Nikos Yiannakouris, Dimitrios Trichopoulos, Heiner Boeing, J Ramon Quiros, Eric J Duell, Esther Molina-Montes, Jose Mara Huerta, Eva Ardanaz, Miren Dorronsoro, Kay-Tee Khaw, Nicholas Wareham Show all

Cancer Epidemiology Biomarkers & Prevention | AMER ASSOC CANCER RESEARCH | Published : 2014

DOI: 10.1158/1055-9965.EPI-14-0247

University of Melbourne Researchers

Gianluca Severi Author Melbourne School of Population and Global Health

Grants

Awarded by ERC-AdG (Norway)

Awarded by ISCIII RETIC (Spain)

Awarded by Cancer Research UK

Awarded by Medical Research Council

Awarded by National Institute for Health Research

Funding Acknowledgements

The salary of Dr. Daniele Campa (first author) was supported by the Portfolio Program Metabolic Dysfunction from the Helmholtz Association. The coordination of EPIC is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, INSERM (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation, the Stavros Niarchos Foundation and the Hellenic Ministry of Health and Social Solidarity (Greece); Italian Association for Research on Cancer (Associazione Italiana per la Ricerca sul Cancro) and National Research Council (Italy); Dutch Ministry of Public Health, Welfare, and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (the Netherlands); ERC-2009-AdG 232997 and Nordforsk, Nordic Centre of Excellence Programme on Food, Nutrition and Health (Norway); Health Research Fund (FIS), Regional Governments of Andalucia, Asturias, Basque Country, Murcia and Navarra, ISCIII RETIC (RD06/0020; Spain); Swedish Cancer Society, Swedish Scientific Council and Regional Government of Skane and Vasterbotten (Sweden); Cancer Research UK, Medical Research Council, Stroke Association, British Heart Foundation, Department of Health, Food Standards Agency, and Wellcome Trust (United Kingdom).